Home » Topics » BioWorld Science

BioWorld Science
RSS

Japanese approval sought for Trelegy Ellipta

May 29, 2018

Chugai seeks Japanese approval for Actemra for cytokine release syndrome

May 29, 2018

REXGEX trial shows importance of immune status for enhanced efficacy with CetuGEX

May 29, 2018

FDA grants priority review for gilteritinib NDA in relapsed or refractory AML

May 29, 2018

IDMC recommends continuation of phase III study of Zepsyre in small cell lung cancer

May 29, 2018

FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis

May 29, 2018

Arroyo BioSciences' AB-22 granted U.S. orphan drug designation for IPF

May 29, 2018

Tazemetostat granted U.S. orphan drug designation for chordoma

May 29, 2018

FDA grants orphan drug designation to SNX-5422 for neuroendocrine tumors

May 29, 2018

ImmuPharma releases further data analysis from pivotal trial of Lupuzor in SLE

May 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...